DFCM
XENE icon

Dark Forest Capital Management’s Xenon Pharmaceuticals XENE Stock Holding History

Dark Forest Capital Management’s Portfolio XENE Stock Details XENE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.34M Buy
+22,234
New +$1.23M 0.09% 416
2026
Q1 		– Sell
-33,459
Closed -$1.5M – 1186
2025
Q4 		$1.5M Buy
+33,459
New +$1.41M 0.07% 508
2023
Q2 		– Sell
-2,455
Closed -$87.9K – 1443
2023
Q1 		$87.9K Buy
+2,455
New +$90.7K 0.02% 700

Other funds holding XENE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Dark Forest Capital Management's XENE Position: Q2 2026 in Review

Dark Forest Capital Management opened a new position in Xenon Pharmaceuticals (XENE) in Q2 2026: 22,234 shares worth $1.34M. The stake represents 0.09% of the portfolio and ranks #416 among its holdings. This is a return to the name: Dark Forest Capital Management previously reported a position in XENE as recently as Q4 2025.

Dark Forest Capital Management first reported a position in XENE in Q1 2023 and has held it in 3 quarters since. The position peaked at $1.5M in Q4 2025. 315 funds tracked by Wall St. Rank hold XENE as of Q2 2026.

  • Dark Forest Capital Management held 22,234 shares of Xenon Pharmaceuticals worth $1.34M as of Q2 2026.
  • Xenon Pharmaceuticals was a new Dark Forest Capital Management position in Q2 2026.
  • Xenon Pharmaceuticals made up 0.09% of Dark Forest Capital Management's portfolio in Q2 2026, its #416 holding.
  • Dark Forest Capital Management first reported a position in Xenon Pharmaceuticals in Q1 2023 and has held it in 3 quarters since.
  • Dark Forest Capital Management's Xenon Pharmaceuticals position peaked at $1.5M in Q4 2025.
  • 315 funds tracked by Wall St. Rank held Xenon Pharmaceuticals as of Q2 2026.

Based on Dark Forest Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.